PLENARY SPEAKER

 Pat Walters, PhD

Chief Data Officer @ Relay Therapeutics

Artificial Intelligence and In Silico ADMET Prediction

 PLENARY SPEAKER

 Parag Mallick, PhD

Founder & Chief Scientist at Nautilus Biotechnology, Associate Professor @ Stanford University

The role of single-cell-omics in drug discovery - Talk Title TBA

 PLENARY SPEAKER

 Malaz Abutarif, PhD

Vice President of Quantitative Clinical Pharmacology @ Daiichi Sankyo

Talk Title TBA

PLENARY SPEAKER

 Steven J Swanson, PhD, FAAPS

Senior Principal Scientist, Bioanalytical Sciences @ Genentech, Inc.

Talk Title TBA

  Eric Tewalt, PhD

Associate Director @ PPD, a part of Thermo Fisher Scientific

Strategies for Assessment of Oligonucleotide Biodistribution in Tissues via Hybridization ELISA

 Jeffrey Kurz, PhD

Associate Director @ Alnylam Pharmaceuticals

The ADME of C16 conjugates for CNS delivery - Title TBA

  Stephen Fowler, PhD

Clinical Pharmacologist @ F. Hoffmann La-Roche Ltd

Title TBA

Andy Pike, PhD

Senior DMPK Lead @ AstraZeneca 

Optimising Proteolysis Targeting Chimeras (PROTAC's) for Oral Drug Delivery: A drug metabolism and pharmacokinetics perspective

  Heather Myler, PhD

Executive Director Scientific Affairs, Analytical Sciences Division @ PPD

Supply Chain Impact on Drug Development: A Pandemic-driven Global Perspective

Christine Callahan, MS

Vice President Supply Chain, Life Sciences Solutions @ Thermo Fisher Scientific

Enhancement of Capacity and Supply Chain Capabilities - Title TBA

  Pallavi Lonkar, PhD

Senior Director, Head of Bioanalytical, DMPK and Biomarkers @ PepGen

 The Promise of Peptide-Oligonucleotide Conjugates for Neuromuscular Diseases

Shelia Breidinger, PhD

Director, Regulated Bioanalytical Outsourcing, Merck & Co, Inc.

Bioanalysis of Molnupiravir - Title TBA

Yue-Ting Wang, PhD

Principal Reserarch Scientist, DMPK-BA @ AbbVie

To Infinity and Beyond Rule of Five Compounds: Challenges & Considerations for Discovery Stage Bioanalytical Support

Weixun Wang, PhD

Group Leader Discovery Bioanalysis, Merck & Co, Inc.

Development of a Target Engagement (TE) Assay for the Oral Peptide PCSK9-LDLr Inhibitor Program

Jacques Saarbach, PhD

Post-doctoral Fellow, Crews Lab, MCDB, Yale University

PROTACs recent developments - Title TBA

Nanda Balasubramanian, PhD

Senior Principal Scientist, Nonclinical Disposition and Bioanalysis, Bristol Myers Squibb

Bioanalytical Strategies and Challenges for CAR-T Support

Tong-Yuan Yang, PhD

Senior Scientific Dierctor @ Janssen R&D; Adjunct Professor @ Department of Pharmacology, College of Medicine, Pennsiylvania State University

Title TBA

Tomomi Kiyota, PhD

Principal Scientist @ Genentech

Renal Proximal Tubule-on-a-Chip: Performance, Utility, and Benefits for Toxicity Mitigation During Drug Development

Jason DelCarpini, PhD

Associate Dierctor, Quantitative Bioanalytics @ Moderna

NAB Assay Strategies - Title TBA

Michele Gunsior, PhD

Senior Director @ Astria Therapeutics

Harmonization of ADA Data Reporting - Title TBA

  Aaron Cooper, PhD

Senior Director of Synthetic Biology @ Arsenal Bio

 Title TBA

Haihong Shi, PhD

Director @ Pfizer

Title TBA

 Donglu Zhang, PhD

Staff Scientist @Genentech

The Importance of Tracking 'Missing' Metabolites - How and Why?

 Hisao Shimizu, PhD

Principal Scientist DMPK @ Takeda Pharmaceutical Company

Title TBA - Bioanalytical Approach for Diverse Oligonucleotides Therapeutics Using Multiple BA Platforms